Overview of Dr. Falchi
Dr. Lorenzo Falchi is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from University of Perugia Faculty of Medicine and has been in practice since 2005. He also speaks multiple languages, including Italian. He specializes in hematologic oncology and is experienced in non-hodgkin lymphoma and immunotherapy.
Office
530 East 74th Street
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2019
Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia , 2012 - 2013- University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2011 - 2012
University of PerugiaSpecialist, Cum Laude, 2005 - 2009
University of Perugia Faculty of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2016 - 2026
NJ State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- ECFMGECFMG Certificate
Awards, Honors, & Recognition
- Future Leaders in Hematology Celgene, 2013
Clinical Trials
- A Study of Mosunetuzumab in People With Follicular Lymphoma Start of enrollment: 2022 May 27
Publications & Presentations
PubMed
- 18 citationsMaesopsin 4-O-β-D-Glucoside, a Natural Compound Isolated from the Leaves of Artocarpus tonkinensis, Inhibits Proliferation and Up-Regulates HMOX1, SRXN1 and BCAS3 in A...Nicola Pozzesi, S Pierangeli, Carmine Vacca, L Falchi, V Pettorossi
Journal of Chemotherapy. 2011-06-01 - 67 citationsOutcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.David Sermer, Connie L Batlevi, M. Lia Palomba, Gunjan L. Shah, Richard J. Lin
Blood Advances. 2020-10-13 - 92 citationsCombined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.Lorenzo Falchi, Helen Ma, Sandra Klein, Jennifer K. Lue, Francesca Montanari
Blood. 2020-11-10
Press Mentions
AbbVie, Genmab's Lymphoma Drug Epkinly Snags FDA Approval in Heated Blood Cancer RaceMay 19th, 2023- 'Remarkable' Study Shows Potential of Chemotherapy-Free Regimen for Follicular LymphomaDecember 13th, 2023
Committees
- Member, Society for immunotherapy of cancer - Early Career Scientists 2016 - Present
Professional Memberships
- Member
- Member
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
